Faithward Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $38.4K | Hold |
|
|||||
|
2025
Q2 | $37.2K | Hold |
|
|||||
|
2025
Q1 | $35.4K | Hold |
|
|||||
|
2024
Q4 | $54.9K | Hold |
|
|||||
|
2024
Q3 | $51K | Hold |
|
|||||
|
2024
Q2 | $41.1K | Hold |
|
|||||
|
2024
Q1 | $113K | Hold |
|
|||||
|
2023
Q4 | $193K | Buy |
|
|||||
|
2023
Q3 | $148K | Buy |
|
|||||
|
2023
Q2 | $219K | Buy |
|
|||||
|
2023
Q1 | $219K | Hold |
|
|||||
|
2022
Q4 | $147K | Hold |
|
|||||
|
2022
Q3 | $104K | Hold |
|
|||||
|
2022
Q2 | $80K | Hold |
|
|||||
|
2022
Q1 | $164K | Buy |
|
|||||
|
2021
Q4 | $266K | Sell |
|
|||||
|
2021
Q3 | $524K | Buy |
|
|||||
|
2021
Q2 | $385K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $285K | Sell |
|
|||||
|
2020
Q3 | $222K | Buy |
|